Fat Grafting
in Breast Reconstruction

What Is Fat Grafting?

Autologous fat grafting — also called lipofilling, lipomodelling, or fat transfer — is the surgical technique of harvesting adipose tissue from a donor site on the patient's own body, processing it to remove blood and oil, and injecting it into a target site to restore volume, correct contour irregularities, or improve tissue quality. Because the graft material is entirely the patient's own, there is no risk of immunological rejection and no introduction of synthetic foreign material.

In the context of breast reconstruction, fat grafting serves two primary roles: as a standalone reconstructive modality for small-volume defects, and — far more commonly — as an adjunct to implant-based reconstruction, where it corrects rippling, improves skin envelope quality, refines contour asymmetries, and enhances long-term aesthetic outcomes.

History and Evolution of Lipofilling

Fat grafting has a longer history than most surgeons appreciate. Early attempts date to the late 19th century, when Neuber (1893) transferred fat autografts to correct facial depressions. However, outcomes were highly unpredictable, and the procedure fell largely out of favour for much of the 20th century due to variable resorption, fat necrosis, and calcification concerns.

The modern era of fat grafting began with the pioneering work of Sidney Coleman in the 1990s, who established the foundational principles of atraumatic harvest, centrifugation-based processing, and small-aliquot microinjection — a methodology now known universally as the Coleman technique. Coleman's 2007 clinical series in Plastic and Reconstructive Surgery demonstrated that these principles, applied to the breast, yielded consistent, safe, and lasting volume augmentation.^[1]

The adoption of fat grafting in breast reconstruction accelerated rapidly after 2010, driven by the convergence of improved harvesting cannula design, validated centrifugation protocols, and growing evidence on oncological safety in post-mastectomy patients. Today, lipofilling is considered an integral component of modern breast reconstruction, endorsed by both the American Society of Plastic Surgeons and the European Association of Plastic Surgeons.

How Fat Grafting Works: The Biological Mechanism

The survival of a fat graft is governed by a complex interaction between transplanted adipocytes, their stromal-vascular support cells, and the vascularity of the recipient site. Understanding this biology is essential for optimising graft take and avoiding complications.

The Adipocyte Survival Model

Upon injection, transplanted fat cells survive by direct plasmatic diffusion of nutrients from the surrounding tissue — a process that can sustain cells within approximately 1–2 mm of the graft surface. Adipocytes at greater distances from recipient vasculature undergo ischaemic necrosis, which is the primary driver of oil cysts, calcifications, and volume loss over time. This is why the Coleman technique's emphasis on small-aliquot, multi-pass injection in fan-shaped tunnels is mechanistically critical: it maximises the surface area-to-volume ratio of the deposited fat, improving cell-to-host interface contact.^[1]

The Stromal-Vascular Fraction

Fat tissue contains far more than adipocytes alone. The stromal-vascular fraction (SVF) — comprising adipose-derived stem cells (ADSCs), endothelial progenitors, pericytes, and macrophages — plays an equally critical role in graft integration. ADSCs secrete pro-angiogenic factors including VEGF and HGF, stimulating neovascularisation within the graft zone. This explains an important clinical observation: irradiated tissues respond particularly well to fat grafting, as the ADSCs appear to remodel fibrotic, radiation-damaged stroma and stimulate local regeneration.^[2]

Volume Retention and Resorption

Volume retention varies widely in the literature — reported ranges of 30–70% at 12 months reflect differences in harvesting technique, processing method, injection volume per tunnel, recipient-site vascularity, and patient factors (BMI, smoking status, radiation history). Standardised closed-system processing, as provided by dedicated fat grafting systems, reduces variability by eliminating operator-dependent processing steps and minimising adipocyte trauma during preparation.

Clinical Applications in Breast Reconstruction

Fat grafting finds application at every stage of the breast reconstruction journey — from immediate prepectoral cases to delayed secondary refinements years post-mastectomy. The key indications are:

• Rippling and implant visibility: The most common indication in implant-based reconstruction. Even 20–30 mL of precisely placed fat over the implant border significantly reduces visible and palpable rippling in thin-flap patients.
• Volume and contour asymmetry: Secondary correction of upper-pole fullness deficits, lateral breast width discrepancies, or inframammary fold irregularities — avoiding the need for implant exchange in many cases.
• Skin envelope preparation (pre-expansion): Repeated fat grafting sessions before reconstruction can expand and improve a contracted or irradiated skin envelope, increasing the options available for definitive reconstruction.
• NAC and areolar complex refinement: Small-volume fat grafting around the neo-nipple or in the areolar zone improves projection, symmetry, and healing after nipple-sparing or nipple reconstruction procedures.
• Radiation sequelae: Fat grafting to irradiated tissue reduces fibrosis, improves pliability, and can restore skin texture — a validated use case with growing evidence supporting ADSC-mediated regenerative effects.^[2]
• Total autologous reconstruction: In selected patients with adequate donor-site volume, repeated large-volume lipofilling sessions can achieve breast mound reconstruction without prosthetic implants — though this requires careful patient selection and multiple procedures.

From Harvest to Injection: The Procedure

A successful fat grafting procedure consists of three distinct phases, each with specific technical requirements that determine graft viability. Standardised, closed-system instrumentation — as offered by EXAFAT — addresses the critical steps of each phase to reduce variability and improve reproducibility across surgeons and centres.

The most technically sensitive step is processing. Open decanting systems expose fat to the theatre environment, risking bacterial contamination and oxidative damage to adipocytes. Dedicated closed-system devices — including the EXAFAT system — maintain sterility and process integrity from harvest cannula to injection syringe without transfer to open containers, reducing these risks while accelerating operative throughput. To understand the purification step in depth, see our dedicated guide to fat dialysis for breast fat grafting.

Fat Grafting vs. Alternative Approaches

EXAFAT — The Closed-System Fat Grafting Solution

Key System Features

• Closed-circuit architecture: Harvest, processing, and injection are performed within a single sterile, sealed system — eliminating the open syringe transfers that introduce contamination risk in traditional Coleman-technique setups.
• Atraumatic lipoaspiration kit: Blunt-tip harvesting cannulas calibrated for low-pressure, low-shear aspiration to maximise viable adipocyte yield from each donor site.
• Integrated centrifugation compatibility: The EXAFAT system is compatible with standard OR centrifuges, allowing standardised 3-minute processing cycles without bespoke equipment.
• Precision injection control: Fine-gauge blunt injection cannulas in multiple lengths for superficial plane microdeposition — enabling targeted correction of rippling at the implant margin, upper-pole hollowing, and NAC zone refinement.
• Volume efficiency: The closed circuit minimises fat loss during transfer steps, increasing the proportion of harvested volume available for injection compared to open processing methods.

Clinical Evidence

Oncological Safety: The Critical Question

The question that occupied reconstructive breast surgeons most intensely in the early 2010s was whether fat grafting near or within the breast of a cancer patient could stimulate tumour recurrence — via ADSC-secreted growth factors or by masking imaging findings. The evidence base has now substantially clarified this concern.

Petit et al. (2012),^[3] in a multicentre study of 321 patients undergoing lipofilling after breast cancer surgery (including 59 with prior breast-conserving surgery), found no statistically significant increase in locoregional recurrence rates compared to matched controls over a mean follow-up of 26 months. Importantly, patients with in situ carcinoma showed a numerical but not statistically significant increase in events, leading the authors to advise caution in this subgroup — a position since adopted in most European guidelines.

Outcomes in Implant-Based Reconstruction

A systematic review and meta-analysis by Groen et al. (2016),^[4] covering 1,330 fat grafting procedures across 18 studies, reported a complication rate of 8.6% for minor complications (oil cysts, palpable nodules, calcifications) and 3.5% for major complications requiring intervention. Patient satisfaction rates were consistently high — above 80% across studies — and implant complication rates were not increased by the addition of lipofilling. The authors concluded that autologous fat grafting is a safe and effective adjunct to implant-based breast reconstruction.

Technique and System Standardisation

Coleman and Saboeiro's landmark 2007 series^[1] of 17 patients undergoing structural fat grafting to the breast demonstrated that adherence to atraumatic harvesting, centrifugation processing, and microinjection technique produced durable volume outcomes with acceptable complication profiles. The series established that outcomes are highly technique-dependent, and directly motivated the development of standardised closed-system platforms — including EXAFAT — designed to make reproducible Coleman-principle fat grafting accessible across surgical centres and experience levels.

Rigotti et al. (2007)^[2] further demonstrated that fat grafting to irradiated tissue produces measurable improvement in skin quality and tissue pliability via ADSC-mediated regenerative mechanisms — broadening the indication beyond volume correction to include radiation damage management in the post-mastectomy setting.

Frequently Asked Questions